Treatment
Treatment is a pharmaceutical drug with 88 clinical trials. Currently 15 active trials ongoing. Historical success rate of 93.0%.
Success Metrics
Based on 40 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
6
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.0%
40 of 46 finished
13.0%
6 ended early
15
trials recruiting
88
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer
Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment
NAD+ Oral Supplement Pilot Intervention in Adult Females
Effect of NMN Supplementation on Organ System Biology
Cervical Thermal Ablation to Treat Persistent HPV Infection
Clinical Trials (88)
ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer
Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment
NAD+ Oral Supplement Pilot Intervention in Adult Females
Effect of NMN Supplementation on Organ System Biology
Cervical Thermal Ablation to Treat Persistent HPV Infection
The Effect of Home-Based Exercise on Chronic Kidney Disease Patients
A Study to Evaluate the Clinical Performance and Safety of UNICON Silicone Hydrogel Daily Disposable Soft Contact Lenses
Clinical Study of EZH2 Inhibitor Combined With PARP Inhibitor in the Treatment of Patients With Advanced or Recurrent Epithelial Ovarian Cancer.
Clinical Efficacy of Using Bioactive Desensitizer Gel
Asan Multivessel Registry
intenSive UpPer Extremity Recovery Program for Chronic Stroke (SUPER)
Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma
The LEADS Trial (Linking Exericise for Advancing Daily Stress Management)
VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC)
Albumin and Crystalloid Administration in Septic Shock
Investigation of Effects of Electrical Stimulation in Women With Vaginal Laxity
Building Emotional Self-Awareness Teletherapy (BEST)
Intra Arrest Ventilation in Human Cadavers II
Mindfulness and Yoga for Pain With Interstitial Cystitis Evaluation
Survival Outcomes of Lung Cancer
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 88